Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1050001.RABbDi8CpV-OL6-i_XcN4q5VssRu-gcFil9TCPiaxbQPs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1050001.RABbDi8CpV-OL6-i_XcN4q5VssRu-gcFil9TCPiaxbQPs130_assertion type Assertion NP1050001.RABbDi8CpV-OL6-i_XcN4q5VssRu-gcFil9TCPiaxbQPs130_head.
- NP1050001.RABbDi8CpV-OL6-i_XcN4q5VssRu-gcFil9TCPiaxbQPs130_assertion description "[To explore this hypothesis, we studied KIRs and their human leukocyte antigen class I ligands in 59 consecutive patients with chronic-phase CML (mean age, 53 years; range, 23-81 years) and a group of 121 healthy control participants belonging to the same ethnic group as the patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1050001.RABbDi8CpV-OL6-i_XcN4q5VssRu-gcFil9TCPiaxbQPs130_provenance.
- NP1050001.RABbDi8CpV-OL6-i_XcN4q5VssRu-gcFil9TCPiaxbQPs130_assertion evidence source_evidence_literature NP1050001.RABbDi8CpV-OL6-i_XcN4q5VssRu-gcFil9TCPiaxbQPs130_provenance.
- NP1050001.RABbDi8CpV-OL6-i_XcN4q5VssRu-gcFil9TCPiaxbQPs130_assertion SIO_000772 23380384 NP1050001.RABbDi8CpV-OL6-i_XcN4q5VssRu-gcFil9TCPiaxbQPs130_provenance.
- NP1050001.RABbDi8CpV-OL6-i_XcN4q5VssRu-gcFil9TCPiaxbQPs130_assertion wasDerivedFrom befree-2016 NP1050001.RABbDi8CpV-OL6-i_XcN4q5VssRu-gcFil9TCPiaxbQPs130_provenance.
- NP1050001.RABbDi8CpV-OL6-i_XcN4q5VssRu-gcFil9TCPiaxbQPs130_assertion wasGeneratedBy ECO_0000203 NP1050001.RABbDi8CpV-OL6-i_XcN4q5VssRu-gcFil9TCPiaxbQPs130_provenance.